• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高迁移率族蛋白1在特发性炎性肌病中的异常表达

Aberrant Expression of High Mobility Group Box Protein 1 in the Idiopathic Inflammatory Myopathies.

作者信息

Day Jessica, Otto Sophia, Cash Kathy, Eldi Preethi, Hissaria Pravin, Proudman Susanna, Limaye Vidya, Hayball John D

机构信息

Experimental Therapeutics Laboratory, University of South Australia Cancer Research Institute, Adelaide, SA, Australia.

School of Pharmacy and Medical Sciences, University of South Australia, Adelaide, SA, Australia.

出版信息

Front Cell Dev Biol. 2020 Apr 17;8:226. doi: 10.3389/fcell.2020.00226. eCollection 2020.

DOI:10.3389/fcell.2020.00226
PMID:32363191
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7180187/
Abstract

INTRODUCTION

High Mobility Group Box Protein 1 (HMGB1) is a DNA-binding protein that exerts inflammatory or pro-repair effects upon translocation from the nucleus. We postulate aberrant HMGB1 expression in immune-mediated necrotising myopathy (IMNM).

METHODS

Herein, we compare HMGB1 expression (serological and sarcoplasmic) in patients with IMNM with that of other myositis subtypes using immunohistochemistry and ELISA.

RESULTS

IMNM ( = 62) and inclusion body myositis (IBM, = 14) patients had increased sarcoplasmic HMGB1 compared with other myositis patients ( = 46). Sarcoplasmic HMGB1 expression correlated with muscle weakness and histological myonecrosis, inflammation, regeneration and autophagy. Serum HMGB1 levels were elevated in patients with IMNM, dermatomyositis and polymositis, and those myositis patients with extramuscular inflammatory features.

DISCUSSION

Aberrant HMGB1 expression occurs in myositis patients and correlates with weakness. A unique expression profile of elevated sarcoplasmic and serum HMGB1 was detected in IMNM.

摘要

引言

高迁移率族蛋白B1(HMGB1)是一种DNA结合蛋白,从细胞核易位后可发挥炎症或促修复作用。我们推测免疫介导的坏死性肌病(IMNM)中存在HMGB1表达异常。

方法

在此,我们使用免疫组织化学和酶联免疫吸附测定法(ELISA)比较IMNM患者与其他肌炎亚型患者的HMGB1表达(血清学和肌浆内)情况。

结果

与其他肌炎患者(n = 46)相比,IMNM患者(n = 62)和包涵体肌炎(IBM,n = 14)患者的肌浆内HMGB1增加。肌浆内HMGB1表达与肌肉无力以及组织学上的肌坏死、炎症、再生和自噬相关。IMNM、皮肌炎和多发性肌炎患者以及那些具有肌肉外炎症特征的肌炎患者血清HMGB1水平升高。

讨论

肌炎患者中存在HMGB1表达异常,且与肌无力相关。在IMNM中检测到肌浆内和血清HMGB1升高的独特表达谱。

相似文献

1
Aberrant Expression of High Mobility Group Box Protein 1 in the Idiopathic Inflammatory Myopathies.高迁移率族蛋白1在特发性炎性肌病中的异常表达
Front Cell Dev Biol. 2020 Apr 17;8:226. doi: 10.3389/fcell.2020.00226. eCollection 2020.
2
Immune-mediated necrotizing myopathy (IMNM): A myopathological challenge.免疫介导性坏死性肌病(IMNM):肌病理的挑战。
Autoimmun Rev. 2022 Feb;21(2):102993. doi: 10.1016/j.autrev.2021.102993. Epub 2021 Nov 16.
3
Clinical and histological features of immune-mediated necrotising myopathy: A multi-centre South Australian cohort study.免疫介导性坏死性肌病的临床和组织学特征:南澳大利亚多中心队列研究。
Neuromuscul Disord. 2020 Mar;30(3):186-199. doi: 10.1016/j.nmd.2020.02.003. Epub 2020 Feb 19.
4
Clinical and pathological features of immune-mediated necrotising myopathies in a single-centre muscle biopsy cohort.单中心肌肉活检队列中免疫介导的坏死性肌病的临床和病理学特征。
BMC Musculoskelet Disord. 2022 May 6;23(1):425. doi: 10.1186/s12891-022-05372-z.
5
Serum cytokine and chemokine profiles in patients with immune-mediated necrotizing myopathy.免疫介导坏死性肌病患者的血清细胞因子和趋化因子谱
J Neuroimmunol. 2022 Apr 15;365:577833. doi: 10.1016/j.jneuroim.2022.577833. Epub 2022 Feb 19.
6
Possible future avenues for myositis therapeutics: DM, IMNM and IBM.肌炎治疗的可能未来途径:DM、IMNM 和 IBM。
Best Pract Res Clin Rheumatol. 2022 Jun;36(2):101762. doi: 10.1016/j.berh.2022.101762. Epub 2022 Jun 28.
7
Radiographic patterns of muscle involvement in the idiopathic inflammatory myopathies.特发性炎性肌病的肌肉受累的影像学表现。
Muscle Nerve. 2019 Nov;60(5):549-557. doi: 10.1002/mus.26660. Epub 2019 Aug 20.
8
Pathophysiological Mechanisms and Treatment of Dermatomyositis and Immune Mediated Necrotizing Myopathies: A Focused Review.皮肌炎和免疫介导性坏死性肌病的病理生理机制与治疗:重点综述。
Int J Mol Sci. 2022 Apr 13;23(8):4301. doi: 10.3390/ijms23084301.
9
Nailfold videocapillaroscopy alterations in dermatomyositis, antisynthetase syndrome, overlap myositis, and immune-mediated necrotizing myopathy.甲褶毛细血管显微镜检查在皮肌炎、抗合成酶综合征、重叠性肌炎和免疫介导性坏死性肌病中的改变。
Clin Rheumatol. 2019 Dec;38(12):3451-3458. doi: 10.1007/s10067-019-04710-2. Epub 2019 Aug 22.
10
Clinical features and prognosis in anti-SRP and anti-HMGCR necrotising myopathy.抗信号识别颗粒和抗 3-羟基-3-甲基戊二酰辅酶 A 还原酶肌炎的临床特征和预后。
J Neurol Neurosurg Psychiatry. 2016 Oct;87(10):1038-44. doi: 10.1136/jnnp-2016-313166. Epub 2016 May 4.

引用本文的文献

1
HMGB1: new biomarker and therapeutic target of autoimmune and autoinflammatory skin diseases.高迁移率族蛋白B1:自身免疫性和自身炎症性皮肤病的新型生物标志物及治疗靶点
Front Immunol. 2025 Apr 16;16:1569632. doi: 10.3389/fimmu.2025.1569632. eCollection 2025.
2
High-mobility group box-1 impedes skeletal muscle regeneration via downregulation of Pax-7 synthesis by increasing miR-342-5p expression.高迁移率族蛋白 B1 通过增加 miR-342-5p 的表达抑制 Pax-7 的合成从而阻碍骨骼肌再生。
Aging (Albany NY). 2023 Nov 13;15(21):12618-12632. doi: 10.18632/aging.205202.
3
The Association of HMGB1 and RAGE Gene Polymorphisms with IgA Vasculitis.

本文引用的文献

1
Association of serum high-mobility group box protein 1 level with outcomes of acute exacerbation of idiopathic pulmonary fibrosis and fibrosing nonspecific interstitial pneumonia.血清高迁移率族蛋白 1 水平与特发性肺纤维化和非特异性间质性肺炎急性加重预后的相关性。
PLoS One. 2018 May 24;13(5):e0196558. doi: 10.1371/journal.pone.0196558. eCollection 2018.
2
High-Mobility Group Box 1-Induced Complement Activation Causes Sterile Inflammation.高迁移率族蛋白 B1 诱导的补体激活导致无菌性炎症。
Front Immunol. 2018 Apr 11;9:705. doi: 10.3389/fimmu.2018.00705. eCollection 2018.
3
224th ENMC International Workshop:: Clinico-sero-pathological classification of immune-mediated necrotizing myopathies Zandvoort, The Netherlands, 14-16 October 2016.
HMGB1 和 RAGE 基因多态性与 IgA 血管炎的关联。
Biochem Genet. 2024 Jun;62(3):2268-2278. doi: 10.1007/s10528-023-10536-0. Epub 2023 Oct 30.
4
Muscle fiber necroptosis in pathophysiology of idiopathic inflammatory myopathies and its potential as target of novel treatment strategy.特发性炎性肌病的病理生理学中的肌肉纤维坏死性细胞死亡及其作为新型治疗策略靶点的潜力。
Front Immunol. 2023 Jul 7;14:1191815. doi: 10.3389/fimmu.2023.1191815. eCollection 2023.
5
HMGB1 Promotes In Vitro and In Vivo Skeletal Muscle Atrophy through an IL-18-Dependent Mechanism.高迁移率族蛋白 B1 通过依赖白细胞介素 18 的机制促进体外和体内骨骼肌萎缩。
Cells. 2022 Dec 6;11(23):3936. doi: 10.3390/cells11233936.
6
Anti-SRP immune-mediated necrotizing myopathy: A critical review of current concepts.抗信号识别颗粒免疫介导的坏死性肌病:对当前概念的批判性回顾。
Front Immunol. 2022 Oct 13;13:1019972. doi: 10.3389/fimmu.2022.1019972. eCollection 2022.
7
Autophagy-related genes are potential diagnostic biomarkers for dermatomyositis.自噬相关基因是皮肌炎潜在的诊断生物标志物。
Ann Transl Med. 2022 Feb;10(4):228. doi: 10.21037/atm-22-70.
8
The Role of HMGB1 in Rheumatic Diseases.HMGB1 在风湿性疾病中的作用。
Front Immunol. 2022 Feb 17;13:815257. doi: 10.3389/fimmu.2022.815257. eCollection 2022.
9
Endoplasmic Reticulum Stress Is Involved in Muscular Pathogenesis in Idiopathic Inflammatory Myopathies.内质网应激参与特发性炎性肌病的肌肉发病机制。
Front Cell Dev Biol. 2022 Feb 14;10:791986. doi: 10.3389/fcell.2022.791986. eCollection 2022.
第224届ENMC国际研讨会:免疫介导性坏死性肌病的临床-血清学-病理学分类,荷兰赞德福特,2016年10月14日至16日。
Neuromuscul Disord. 2018 Jan;28(1):87-99. doi: 10.1016/j.nmd.2017.09.016. Epub 2017 Oct 23.
4
High mobility group box 1 orchestrates tissue regeneration via CXCR4.高迁移率族蛋白 B1 通过 CXCR4 调控组织再生。
J Exp Med. 2018 Jan 2;215(1):303-318. doi: 10.1084/jem.20160217. Epub 2017 Dec 4.
5
Serum HMGB1 as a Potential Biomarker for Patients with Asbestos-Related Diseases.血清高迁移率族蛋白B1作为石棉相关疾病患者的潜在生物标志物。
Dis Markers. 2017;2017:5756102. doi: 10.1155/2017/5756102. Epub 2017 Mar 1.
6
Dysregulated innate immune function in the aetiopathogenesis of idiopathic inflammatory myopathies.特发性炎性肌病发病机制中的先天免疫功能失调。
Autoimmun Rev. 2017 Jan;16(1):87-95. doi: 10.1016/j.autrev.2016.09.019. Epub 2016 Sep 22.
7
HMGB1 May Be a Biomarker for Predicting the Outcome in Patients with Polymyositis /Dermatomyositis with Interstitial Lung Disease.高迁移率族蛋白B1可能是预测多发性肌炎/皮肌炎合并间质性肺病患者预后的生物标志物。
PLoS One. 2016 Aug 18;11(8):e0161436. doi: 10.1371/journal.pone.0161436. eCollection 2016.
8
A novel high mobility group box 1 neutralizing chimeric antibody attenuates drug-induced liver injury and postinjury inflammation in mice.一种新型的高迁移率族蛋白B1中和嵌合抗体可减轻小鼠药物性肝损伤及损伤后炎症反应。
Hepatology. 2016 Nov;64(5):1699-1710. doi: 10.1002/hep.28736. Epub 2016 Sep 1.
9
High Mobility Group Box Protein 1 (HMGB1): The Prototypical Endogenous Danger Molecule.高迁移率族蛋白B1(HMGB1):典型的内源性危险分子。
Mol Med. 2015 Oct 27;21 Suppl 1(Suppl 1):S6-S12. doi: 10.2119/molmed.2015.00087.
10
Comments on "Preliminary study of high mobility group box chromosomal protein 1(HMGB1) in ankylosing spondylitis patients ".关于“强直性脊柱炎患者高迁移率族蛋白B1(HMGB1)的初步研究”的评论
Clin Exp Rheumatol. 2016 Jan-Feb;34(1):155. Epub 2015 Oct 30.